Paper36908850
miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy.
Wang W and 2 others. Genet Res (Camb), 2023. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy. Papers, record 36908850. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36908850
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Uterine Cervical Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| Female | |
| HeLa Cells | |
| Cell Movement | |
| Cell Proliferation | |
| Autophagy | |
| PTEN Phosphohydrolase |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26555006 | PTEN and PI3K/AKT in non-small-cell lung cancer. | Pharmacogenomics | 2015 | https://conductscience.org/library/papers/26555006 | PubMed |
| 2 | 25664686 | Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. | Med Sci Monit Basic Res | 2015 | https://conductscience.org/library/papers/25664686 | PubMed |
| 3 | 33023313 | miR-19 Promotes Cell Proliferation, Invasion, Migration, and EMT by Inhibiting SPRED2-mediated Autophagy in Osteosarcoma Cells. | Cell Transplant | 2020 | https://conductscience.org/library/papers/33023313 | PubMed |
| 4 | 19115209 | Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. | Int J Cancer | 2009 | https://conductscience.org/library/papers/19115209 | PubMed |
| 5 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 6 | 8876633 | Papillomavirus infections--a major cause of human cancers. | Biochim Biophys Acta | 1996 | https://conductscience.org/library/papers/8876633 | PubMed |
| 7 | 28410191 | Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28410191 | PubMed |
| 8 | 28290615 | MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5. | Genet Mol Res | 2017 | https://conductscience.org/library/papers/28290615 | PubMed |
| 9 | 34239562 | Exosomes miR-22-3p Derived from Mesenchymal Stem Cells Suppress Colorectal Cancer Cell Proliferation and Invasion by Regulating RAP2B and PI3K/AKT Pathway. | J Oncol | 2021 | https://conductscience.org/library/papers/34239562 | PubMed |
| 10 | 31317006 | miR-19b-3p promotes human pancreatic cancer Capan-2 cells proliferation by targeting phosphatase and tension homolog. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/31317006 | PubMed |
| 11 | 30556877 | Analysis on expression level and diagnostic value of miR-19 and miR-21 in peripheral blood of patients with undifferentiated lung cancer. | Eur Rev Med Pharmacol Sci | 2018 | https://conductscience.org/library/papers/30556877 | PubMed |
| 12 | 32151082 | MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1. | Cells | 2020 | https://conductscience.org/library/papers/32151082 | PubMed |
| 13 | 19682430 | MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19682430 | PubMed |
| 14 | 3032634 | Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow-up of 513 women for two years. | Eur J Gynaecol Oncol | 1987 | https://conductscience.org/library/papers/3032634 | PubMed |
| 15 | 29399123 | MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29399123 | PubMed |
| 16 | 35933332 | Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35933332 | PubMed |
| 17 | 33990639 | Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/33990639 | PubMed |
| 18 | 30646925 | Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30646925 | PubMed |
| 19 | 29985991 | MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells. | Carcinogenesis | 2018 | https://conductscience.org/library/papers/29985991 | PubMed |
| 20 | 29457830 | miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis. | Int J Cancer | 2018 | https://conductscience.org/library/papers/29457830 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42584802 | hnRNP A1 controls MIR17HG alternative splicing and maturation of miR-19a. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42584802 | PubMed |
| 42568545 | Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming. | Front Immunol | 2026 | https://conductscience.org/library/papers/42568545 | PubMed |
| 42220006 | Complementary ROC-Derived Indices for Screening Improper Expression Profiles in RNA-Seq Differential Expression Analysis. | Balkan Med J | 2026 | https://conductscience.org/library/papers/42220006 | PubMed |
| 41476282 | The role of microRNAs on autophagy in cervical cancer: review. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41476282 | PubMed |
| 41301038 | Interplay Between MicroRNAs and Breast Cancer Therapies: Personalized Therapeutic Potential for HER2-Low Breast Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301038 | PubMed |
| 41113458 | The potential role of miR-155 in the tumorigenesis of cervical cancer. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41113458 | PubMed |
| 40728024 | Association of exosomal miR17-92a cluster and target genes with breast cancer risk. | Future Oncol | 2025 | https://conductscience.org/library/papers/40728024 | PubMed |
| 40537770 | LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40537770 | PubMed |
| 40448098 | CircSLC22A3 inhibits the invasion and metastasis of ESCC via the miR-19b-3p/TRAK2 axis and by reducing the stability of m6A-modified ACSBG1 mRNA. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40448098 | PubMed |
| 40413660 | The role and diagnostic value of deregulated miRNAs in cervical cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40413660 | PubMed |
| 40251577 | To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40251577 | PubMed |
| 39789663 | Mir-615-5p inhibits cervical cancer progression by targeting TMIGD2. | Hereditas | 2025 | https://conductscience.org/library/papers/39789663 | PubMed |
| 39651653 | New thiazolidin-4-ones as anti-cervical cancer agents targeting EGFR: design, synthesis, and computational studies. | Future Med Chem | 2025 | https://conductscience.org/library/papers/39651653 | PubMed |
| 39253193 | miR-19a-3p promotes the growth of hepatocellular carcinoma by regulating p53/SOX4. | Heliyon | 2024 | https://conductscience.org/library/papers/39253193 | PubMed |
| 38892054 | How MicroRNAs Command the Battle against Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892054 | PubMed |
| 38509890 | The importance of protein domain mutations in cancer therapy. | Heliyon | 2024 | https://conductscience.org/library/papers/38509890 | PubMed |
| 37373102 | PTEN Inhibitor Treatment Lowers Muscle Plasma Membrane Damage and Enhances Muscle ECM Homeostasis after High-Intensity Eccentric Exercise in Mice. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373102 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36908850
GET https://conductscience.org/api/papers/v1/36908850/references?page=2